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Introduction
Low first-dose peak serum concentrations of amikacin
and gentamicin are reported in intensive care unit (ICU)
patients.1
Objectives
The present study aimed at assessing the impact of giv-
ing high doses of amikacin (30 mg/kg) or gentamicin
(8 mg/kg) in ICU patients with severe sepsis.
Methods
Single-center observational study. All ICU patients with
clinical indication of aminoglycosides were eligible.ICU
physicians were encouraged to administer maximal
recommended doses of amikacin and gentamicin
(30 and 8 mg/kg, respectively). The first and subsequent
doses and corresponding peak plasma concentrations
were recorded. Guideline targets for serum concentra-
tions were used with ≥60 and ≥30 mg/L for amikacin
and gentamicin, respectively. A target pharmacokinetic/
pharmacodynamic (PK/PD) ratio of 10-times the minimal
inhibitory concentration (10xMIC) was also measured.
Results
Sixty-three ICU patients (39 males, 68 ± 16 years, 75 ± 22
kg, 168 ± 8 cm, SAPS II = 43 ± 16) with severe sepsis and
an indication for IV amikacin (n= 47) or gentamicin (n =
16), were included. Pulmonary, abdominal and urinary
tract infections were diagnosed in 56 patients. Infection
was confirmed in 37 (59%) patients. The target first-dose
peak serum concentration was achieved in 37/63 patients
(59%)(36/47 (77%) and 1/16 (6%) patient for amikacin and
gentamicin, respectively). 59/63 (94%) patients achieved
the PK/PD target using the MIC data that was available
from 21 patients. However, the subsequent injection
should be cancelled in nearly half of patients due to a too
high trough, without renal function impairment.
Conclusions
30 mg/kg amikacin and 8 mg/kg gentamicin doses led
to adequate peak serum concentrations in 59% patients
using guideline targets.
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Figure 1 Amikacin peak concentrations after the first dose.
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